Rep. Julie Johnson Purchases Shares of CME Group Inc. (NASDAQ:CME)

Key Points

• Representative Julie Johnson recently purchased shares of CME Group Inc. (NASDAQ:CME), investing between $1,001 and $15,000 on August 11th.
• CME Group will pay a quarterly dividend of $1.25 on September 25th, signaling a 1.9% annualized yield for shareholders.
• CME Group reported $2.96 earnings per share for its last quarter, surpassing estimates and marking a 10.4% year-over-year revenue increase.

Representative Julie Johnson (D-Texas) recently bought shares of CME Group Inc. NASDAQ: CME. In a filing disclosed on September 11th, the Representative disclosed that they had bought between $1,001 and $15,000 in CME Group stock on August 11th. The trade occurred in the Representative's "CHASE BROKERAGE ACCOUNT (3935)" account.

Representative Julie Johnson also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of McDonald's NYSE: MCD on 8/14/2025.
• Sold $1,001 - $15,000 in shares of Eli Lilly and Company NYSE: LLY on 8/14/2025.
• Sold $1,001 - $15,000 in shares of Arthur J. Gallagher & Co. NYSE: AJG on 8/14/2025.
• Sold $1,001 - $15,000 in shares of Parker-Hannifin NYSE: PH on 8/14/2025.
• Sold $1,001 - $15,000 in shares of Charles Schwab NYSE: SCHW on 8/14/2025.
• Sold $1,001 - $15,000 in shares of Fidelity National Information Services NYSE: FIS on 8/14/2025.
• Sold $1,001 - $15,000 in shares of ConocoPhillips NYSE: COP on 8/14/2025.
• Sold $1,001 - $15,000 in shares of Home Depot NYSE: HD on 8/14/2025.
• Sold $1,001 - $15,000 in shares of Dover NYSE: DOV on 8/14/2025.
• Sold $1,001 - $15,000 in shares of UnitedHealth Group NYSE: UNH on 8/14/2025.

CME Group Stock Performance

Shares of NASDAQ CME opened at $262.30 on Monday. The firm has a market cap of $94.53 billion, a price-to-earnings ratio of 25.39, a P/E/G ratio of 4.75 and a beta of 0.43. CME Group Inc. has a one year low of $212.38 and a one year high of $290.79. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The stock's fifty day moving average price is $273.60 and its two-hundred day moving average price is $270.59.

CME Group (NASDAQ:CME - Get Free Report) last released its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The company had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same period in the prior year, the firm posted $2.56 EPS. CME Group's quarterly revenue was up 10.4% on a year-over-year basis. On average, equities analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th will be issued a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date of this dividend is Tuesday, September 9th. CME Group's dividend payout ratio is currently 48.40%.

Insider Buying and Selling

In other news, insider Sunil Cutinho sold 11,896 shares of the company's stock in a transaction that occurred on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the transaction, the insider owned 17,440 shares of the company's stock, valued at approximately $4,734,436.80. This represents a 40.55% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director William R. Shepard bought 256 shares of the business's stock in a transaction dated Wednesday, June 25th. The shares were acquired at an average cost of $270.53 per share, for a total transaction of $69,255.68. Following the purchase, the director owned 258,196 shares of the company's stock, valued at approximately $69,849,763.88. The trade was a 0.10% increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 0.30% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on CME shares. Erste Group Bank downgraded CME Group from a "strong-buy" rating to a "hold" rating in a research report on Saturday, May 24th. Piper Sandler boosted their price objective on CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a research report on Tuesday, July 15th. UBS Group dropped their price target on CME Group from $305.00 to $285.00 and set a "neutral" rating on the stock in a research report on Monday, September 8th. Wall Street Zen cut CME Group from a "hold" rating to a "sell" rating in a report on Sunday, July 13th. Finally, Oppenheimer increased their price objective on CME Group from $300.00 to $303.00 and gave the company an "outperform" rating in a research report on Thursday, July 24th. Four equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, CME Group presently has a consensus rating of "Hold" and an average price target of $260.60.

Institutional Trading of CME Group

A number of institutional investors and hedge funds have recently modified their holdings of the business. Webster Bank N. A. grew its holdings in shares of CME Group by 206.9% in the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider's stock worth $25,000 after acquiring an additional 60 shares during the period. Highline Wealth Partners LLC increased its holdings in shares of CME Group by 84.3% in the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider's stock worth $26,000 after purchasing an additional 43 shares during the last quarter. Wayfinding Financial LLC bought a new stake in shares of CME Group in the first quarter worth about $25,000. Cornerstone Planning Group LLC increased its holdings in shares of CME Group by 122.2% in the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock worth $26,000 after purchasing an additional 55 shares during the last quarter. Finally, Sagard Holdings Management Inc. bought a new stake in CME Group during the second quarter worth approximately $30,000. Institutional investors own 87.75% of the company's stock.

About Representative Johnson

Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas' 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027. Johnson (Democratic Party) ran for election to the U.S. House to represent Texas' 32nd Congressional District. She won in the general election on November 5, 2024. Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson's career experience includes working as an attorney.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.